Cargando…

Anticoagulation for Stroke Prevention in Older Adults with Atrial Fibrillation and Comorbidity: Current Evidence and Treatment Challenges

The burden of atrial fibrillation (AF) is projected to increase substantially over the next decade in parallel with the aging of the population. The increasing age, level of comorbidity, and polypharmacy will complicate the treatment of older adults with AF. For instance, advanced age and chronic ki...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sabbag, Avi, Yao, Xiaoxi, Siontis, Konstantinos C., Noseworthy, Peter A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Cardiology 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6158453/ https://www.ncbi.nlm.nih.gov/pubmed/30238705 http://dx.doi.org/10.4070/kcj.2018.0261

Ejemplares similares

Is Atrial Fibrillation Management as Simple as ABC?
por: Yao, Xiaoxi, et al.
Publicado: (2020)

On-treatment follow-up in real-world studies of direct oral anticoagulants in atrial fibrillation: Association with treatment effects
por: Hutto, David, et al.
Publicado: (2022)

Stroke Prophylaxis in Patients with Atrial Fibrillation and End-Stage Renal Disease
por: van Zyl, Martin, et al.
Publicado: (2020)

Patterns of Anticoagulation Use and Cardioembolic Risk After Catheter Ablation for Atrial Fibrillation
por: Noseworthy, Peter A., et al.
Publicado: (2015)

Atrial Fibrillation and Cancer: Where Biology and Epidemiology Intertwine
por: Siontis, Konstantinos C., et al.
Publicado: (2021)

Contemporary trends and barriers to oral anticoagulation therapy in Non-valvular atrial fibrillation during DOAC predominant era
por: Sehrawat, Ojasav, et al.
Publicado: (2023)

Effect of Adherence to Oral Anticoagulants on Risk of Stroke and Major Bleeding Among Patients With Atrial Fibrillation
por: Yao, Xiaoxi, et al.
Publicado: (2016)

Stroke prevention in patients with atrial fibrillation and comorbidities: evidence and common sense
por: de Groot, J. R.
Publicado: (2020)

Rivaroxaban as an oral anticoagulant for stroke prevention in atrial fibrillation
por: Turpie, Alexander GG
Publicado: (2014)

Anticoagulants for Stroke Prevention in Atrial Fibrillation in Elderly Patients
por: Schäfer, Andreas, et al.
Publicado: (2020)

Novel oral anticoagulants for stroke prevention in atrial fibrillation: a focus on the older patient
por: Yates, Scott W
Publicado: (2013)

Baseline characteristics and event rates among anticoagulated patients with atrial fibrillation in practice and pivotal NOAC trials
por: Noseworthy, Peter A., et al.
Publicado: (2017)

Atrial fibrillation in older patients—reducing stroke risk is not only about anticoagulation
por: Win, Nay Thu, et al.
Publicado: (2016)

Stroke prevention in the elderly atrial fibrillation patient with comorbid conditions: focus on non-vitamin K antagonist oral anticoagulants
por: Turagam, Mohit K, et al.
Publicado: (2015)

Sepsis-driven atrial fibrillation and ischaemic stroke. Is there enough evidence to recommend anticoagulation?
por: Induruwa, Isuru, et al.
Publicado: (2022)

Editorial: Effects of oral anticoagulant therapy in atrial fibrillation patients with comorbidities
por: Li, Runkai, et al.
Publicado: (2023)

Anticoagulation Control in Older Atrial Fibrillation Patients Receiving Vitamin K Antagonist Therapy for Stroke Prevention
por: Zulkifly, Hanis, et al.
Publicado: (2022)

Oral anticoagulation to reduce risk of stroke in patients with atrial fibrillation: current and future therapies
por: Amin, Alpesh
Publicado: (2013)

Preventing stroke in atrial fibrillation patients – clinical utility of oral anticoagulants
por: Jhawar, Manish B, et al.
Publicado: (2012)

Prior Anticoagulation in Patients with Ischemic Stroke and Atrial Fibrillation
por: Meinel, Thomas R., et al.
Publicado: (2020)

Atrial Fibrillation and Ischemic Stroke despite Oral Anticoagulation
por: Galea, Roberto, et al.
Publicado: (2023)

Atrial fibrillation, electroconvulsive therapy, stroke risk, and anticoagulation
por: Kapadia, Meera, et al.
Publicado: (2023)

Anticoagulation in atrial fibrillation
por: Steinberg, Benjamin A, et al.
Publicado: (2014)

Oral anticoagulant use for stroke prevention in atrial fibrillation patients with difficult scenarios
por: Chang, Ting-Yung, et al.
Publicado: (2018)

Barriers to stroke prevention in Atrial Fibrillation: Insights from the global anticoagulation Roundtable
por: Barnes, Geoffrey D., et al.
Publicado: (2022)

Cognitive Function: Is There More to Anticoagulation in Atrial Fibrillation Than Stroke?
por: Cao, Lin, et al.
Publicado: (2015)

Etiology of Ischemic Strokes of Patients with Atrial Fibrillation and Therapy with Anticoagulants
por: Purrucker, Jan C., et al.
Publicado: (2020)

Discontinuation of oral anticoagulation in atrial fibrillation and risk of ischaemic stroke
por: García Rodríguez, Luis Alberto, et al.
Publicado: (2021)

Adherence to oral anticoagulation in ischemic stroke patients with atrial fibrillation
por: Tiili, Paula, et al.
Publicado: (2021)

Oral Anticoagulants in the Oldest Old with Recent Stroke and Atrial Fibrillation
por: Polymeris, Alexandros A., et al.
Publicado: (2021)

Challenges of Anticoagulant Therapy in Atrial Fibrillation—Focus on Gastrointestinal Bleeding
por: Scridon, Alina, et al.
Publicado: (2023)

Percutaneous Left Atrial Appendage Occlusion in Comparison to Non‐Vitamin K Antagonist Oral Anticoagulant Among Patients With Atrial Fibrillation
por: Noseworthy, Peter A., et al.
Publicado: (2022)

Stroke Prevention in Atrial Fibrillation: Understanding the New Oral Anticoagulants Dabigatran, Rivaroxaban, and Apixaban
por: Ru San, Tan, et al.
Publicado: (2012)

The Primary Goal of Anticoagulation in Atrial Fibrillation to Prevent Stroke and Not to Offer the Apparently Cheapest Treatment
por: Diener, Hans-Christoph
Publicado: (2014)

Stroke Prevention in Atrial Fibrillation: A Clinical Perspective on Trials of the Novel Oral Anticoagulants
por: Morais, João, et al.
Publicado: (2016)

Trials of Novel Oral Anticoagulants for Stroke Prevention In Patients with Non-valvular Atrial Fibrillation
por: Halperin, Jonathan L, et al.
Publicado: (2014)

Non-Vitamin K Oral Anticoagulants for Stroke Prevention in Special Populations with Atrial Fibrillation
por: Bisson, Arnaud, et al.
Publicado: (2017)

Stroke Prevention in Atrial Fibrillation in the Very Elderly: Anticoagulant Therapy Is No Longer a Sin
por: Ansell, Jack
Publicado: (2017)

Non-vitamin K oral anticoagulants for secondary stroke prevention in patients with atrial fibrillation
por: Diener, Hans-Christoph, et al.
Publicado: (2020)

Stroke prevention within primary care: management of atrial fibrillation using oral anticoagulation
por: Lotufo, Paulo Andrade
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_n7tm58hk6coo95ro66750qhov6